AEP
53
2
PVH
57
5
JNJ
44
3
HBAN
56
2
SHW
65
7
PPG
60
3
ISRG
76
2
THC
55
-4
UNP
45
6
NWL
50
6
XYL
45
8
DGX
50
2
SWKS
49
11
A
41
5
CNP
63
3
LEN
52
2
MRO
40
-15
HD
55
8
CAH
53
6
RL
68
3
AEP
53
2
PVH
57
5
JNJ
44
3
HBAN
56
2
SHW
65
7
PPG
60
3
ISRG
76
2
THC
55
-4
UNP
45
6
NWL
50
6
XYL
45
8
DGX
50
2
SWKS
49
11
A
41
5
CNP
63
3
LEN
52
2
MRO
40
-15
HD
55
8
CAH
53
6
RL
68
3
Financhill
Back

Cidara Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
81

CDTX
Cidara Therapeutics

Last Price:
20.68
Seasonality Move:
12.66%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Cidara Therapeutics Price Quote

$20.68
+3.23 (+18.51%)
(Updated: November 22, 2024 at 5:15 PM ET)

Cidara Therapeutics Key Stats

Buy
81
Cidara Therapeutics (CDTX) is a Buy
Day range:
$17.17 - $19.98
52-week range:
$10.00 - $24.40
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.43
P/B ratio:
1.06%
Volume:
450.9K
Avg. volume:
37.4K
1-year change:
19.11%
Market cap:
$123M
Revenue:
$63.9M
EPS:
$-25.36

How Much Does Cidara Therapeutics Make?

Data Unavailable

Is Cidara Therapeutics Growing As A Company?

Data Unavailable

Cidara Therapeutics Stock Price Performance

What Is Cidara Therapeutics 52-Week High & Low?

Cidara Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cidara Therapeutics?

Is Cidara Therapeutics Cash Flow Positive?

  • What Is CDTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$159.8M
  • What Is Cidara Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $238.9M
  • What Is Cidara Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$307K

Cidara Therapeutics Return On Invested Capital

Data Unavailable

Cidara Therapeutics Earnings Date & Stock Price

Cidara Therapeutics Competitors

Cidara Therapeutics Dividend Yield

Cidara Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 56.25%
Revenue: 0% -100%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 27.33
Upside from Last Price: 56.64%

Major Shareholders

  • How many CDTX shares are owned by institutional investors?
    16.6M CDTX shares are owned by institutional investors
  • How many CDTX shares are owned by insiders?
    1.5M CDTX shares are owned by insiders